View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Novo Nordisk Pharmatech
26 October 2017

Novo Nordisk Pharmatech to Showcase Insulin Human AF World Biosimilar Congress

Novo Nordisk Pharmatech has announced it will be showcasing its innovative biologics and Insulin Human AF at the World Biosimilar Congress in Switzerland.

To be held from 31 October to 1 November at Congress Center Basel, the congress is a commercially focused event bringing together the full value chain. It looks at commercialising and pushing forward adoption of biosimilars globally.

Novo Nordisk Pharmatech invites you to visit booth #53 to discover more about recombinant insulin for innovative biologics and Insulin Human AF.

Novo Nordisk Pharmatech is one of the leading worldwide suppliers of recombinant insulin. A key component in serum-free growth media for mammalian cells, the company’s recombinant insulin products are approved by regulatory bodies worldwide, including the US Food and Drink Administration (FDA) and European Medicines Agency (EMA). Its products are manufactured to current good manufacturing practice (cGMP) standards and the company guarantees:

  • Global regulatory compliance
  • Consistent high quality
  • Extensive regulatory documentation
  • Continuous availability
  • Secure global supply chain
  • High levels of service and support

Novo Nordisk Pharmatech delivers a proven record of product purity, reliability, and consistency, as well as custom quality products for future therapies.

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology